Anti-Rex aptamers as mimics of the Rex-binding element

Journal of Virology

Volumn 73, Issue 6, 1999, Pages 4962-4971

  Baskerville, Scott ^a,d   Zapp, Maria ^b   Ellington, Andrew D ^a,c  

^a INDIANA UNIVERSITY   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c The University of Texas at Austin   (United States)

^d WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

REX PROTEIN; RNA BINDING PROTEIN;

ARTICLE; BINDING AFFINITY; BINDING SITE; HUMAN T CELL LEUKEMIA VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN RNA BINDING;

EID: 0032993641     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.6.4962-4971.1999     Document Type: Article

References (62)

1. Aboul-ela, F., J. Karn, and G. Varani. 1995. The structure of the human immunodeficiency virus type-1 TAR RNA reveals principles of RNA recognition by Tat protein. J. Mol. Biol. 253:313-332.
2. Ahmed, Y. F., S. M. Hanly, M. H. Malim, B. R. Cullen, and W. C. Greene. 1990. Structure-function analyses of the HTLV-I Rex and HIV-1 Rev RNA response elements: insights into the mechanism of Rex and Rev action. Genes Dev. 4:1014-1022.
3. Askjaer, P., and J. Kjems. 1998. Mapping multiple RNA binding sites of human T-cell lymphotropic virus type I Rex protein within 5′- and 3′-Rex response elements. J. Biol. Chem. 273:11463-11471.
4. Bartel, D. P., M. L. Zapp, M. R. Green, and J. W. Szostak. 1991. HIV-1 Rev regulation involves recognition of non-Watson-Crick base pairs in viral RNA. Cell 67:529-536.
5. Baskerville, S., M. Zapp, and A. D. Ellington. 1995. High-resolution mapping of the human T-cell leukemia virus type 1 Rex-binding element by in vitro selection. J. Virol. 69:7559-7569.
6. Beraud, C., G. Lombard-Platet, Y. Michal, and P. Jalinot. 1991. Binding of the HTLV-1 Tax 1 transactivator to the inducible 21 bp enhancer is mediated by the cellular factor HEB1. EMBO J. 10:3795-3803.
7. Bogerd, H. P., R. A. Fridell, S. Madore, and B. R. Cullen. 1995. Identification of a novel cellular cofactor for the Rev/Rex class of retroviral regulatory proteins. Cell 82:485-494.
8. Bogerd, H. P., G. L. Huckaby, Y. F. Ahmed, S. M. Hanly, and W. C. Greene. 1991. The type I human T-cell leukemia virus (HTLV-I) Rex trans-activator binds directly to the HTLV-I Rex and the type 1 human immunodeficiency virus Rev RNA response elements. Proc. Natl. Acad. Sci. USA 88:5704-5708.
9. Bogerd, H. P., L. S. Tiley, and B. R. Cullen. 1992. Specific binding of the human T-cell leukemia virus type I Rex protein to a short RNA sequence located within the Rex response element. J. Virol. 66:7572-7575.
10. Bohnlein, E., J. Berger, and J. Hauber. 1991. Functional mapping of the human immunodeficiency virus type 1 Rev RNA binding domain: new insights into the domain structure of Rev and Rex. J. Virol. 45:7051-7055.
11. Cullen, B. R. 1992. Mechanism of action of regulatory proteins encoded by complex retroviruses. Microbiol. Rev. 56:375-394.
12. Ellington, A. D., and R. Conrad. 1995. Aptamers as potential nucleic acid pharmaceuticals. Biotechnol. Annu. Rev. 1:185-214.
13. Fritz, C. C., M. L. Zapp, and M. R. Green. 1995. A human nucleoporin-like protein that specifically interacts with HIV Rev. Nature 376:530-533.
14. Fu, L., and K. N. White. 1996. Enhancement of nucleocytoplasmic export of HTLV-I Rex mRNA through cis and trans interactions of the mRNA with the complex of Rex protein and Rex-responsive element. FEBS Lett. 396: 47-52.
15. Gessain, A., F. Barin, J. C. Vernant, O. Gout, L. Maurs, A. Calender, and G. de The. 1985. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet ii:407-410.
16. Giver, L., D. Bartel, M. Zapp, A. Pawul, M. Green, and A. D. Ellington. 1993. Selective optimization of the Rev-binding element of HIV-1. Nucleic Acids res. 21:5509-5516.
17. Giver, L., D. P. Bartel, M. I. Zapp, M. R. Green, and A. D. Ellington. 1993. Selection and design of high-affinity RNA ligands for HIV-1 Rev. Gene 137:19-24.
18. Gold, L. 1995. Conformational properties of oligonucleotides. Nucleic Acids Symp. Ser. 33:20-22.
19. Good, P. D., A. J. Krikos, S. X. Li, E. Bertrand, N. S. Lee, L. Giver, A. Ellington, J. A. Zaia, J. J. Rossi, and D. R. Engelke. 1997. Expression of small, therapeutic RNAs in human cell nuclei. Gene Ther. 4:45-54.
20. Grassmann, R., S. Berchtold, C. Aepinus, C. Ballaun, E. Bothnlein, and B. Fleckenstein. 1991. In vitro binding of human T-cell leukemia virus rex proteins to the rex-response element of viral transcripts. J. Virol. 65:3721-3727.
21. Grone, M., E. Hoffmann, S. Berchtold, B. R. Cullen, and R. Grassmann. 1994. A single stem-loop structure within the HTLV-1 Rex response element is sufficient to mediate Rex activity in vivo. Virology 204:144-152.
22. Grone, M., C. Koch, and R. Grassmann. 1996. The HTLV-1 Rex protein induces nuclear accumulation of unspliced viral RNA by avoiding intron excision and degradation. Virology 218:316-325.
23. Hammes, S. R., and W. C. Greene. 1993. Multiple arginine residues within the basic domain of HTLV-I Rex are required for specific RNA binding and function. Virology 193:41-49.
24. Hanly, S. M., L. T. Rimsky, M. H. Malim, J. H. Kim, J. Hauber, M. Duc Dodon, S. Y. Le, J. V. Maizel, B. R. Cullen, and W. C. Greene. 1989. Comparative analysis of the HTLV-I Rex and HIV-1 Rev trans-regulatory proteins and their RNA response elements. Genes Dev. 3:1534-1544.
25. Hidaka, M., J. Inoue, M. Yoshida, and M. Seild. 1988. Post-transcriptional regulator (rex) of HTLV-1 initiates expression of viral structural proteins but suppresses expression of regulatory proteins. EMBO J. 7:519-523.
26. Hinuma, Y., K. Nagata, M. Hanaoka, M. Nakai, T. Matsumoto, K. I. Kinoshita, S. Shirakawa, and I. Miyoshi. 1981. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc. Natl. Acad. Sci. USA 78:6476-6480.
27. Hofer, L., I. Weichselbraun, S. Quick, G. K. Farrington, E. Bohnlein, and J. Hauber. 1991. Mutational analysis of the human T-cell leukemia virus type I trans-acting rex gene product. J. Virol. 65:3379-3383.
28. Hope, T. J., B. L. Bond, D. McDonald, N. P. Klein, and T. G. Parslow. 1991. Effector domains of human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex are functionally interchangeable and share an essential peptide motif. J. Virol. 65:6001-6007.
29. Hope, T. J., D. McDonald, X. J. Huang, J. Low, and T. G. Parslow. 1990. Mutational analysis of the human immunodeficiency virus type 1 Rev transactivator: essential residues near the amino terminus. J. Virol. 64:5360-5366.
30. Inoue, J., M. Yoshida, and M. Seiki. 1987. Transcriptional (p40x) and posttranscriptional (p27x-III) regulators are required for the expression and replication of human T-cell leukemia virus type I genes. Proc. Natl. Acad. Sci. USA 84:3653-3657.
31. Jensen, K. B., L. Green, S. MacDougal-Waugh, and C. Tuerk. 1994. Characterization of an in vitro-selected RNA ligand to the HIV-1 Rev protein. J. Mol. Biol. 235:237-247.
32. King, S. J., and M. Famulok. 1994. All you wanted to know about SELEX. Mol. Biol. Rep. 20:97-107.
33. Lee, S. W., H. F. Gallardo, E. Gilboa, and C. Smith. 1994. Inhibition of human immunodeficiency virus type 1 in human T cells by a potent Rev response element decoy consisting of the 13-nucleotide minimal Rev-binding domain. J. Virol. 68:8254-8264.
34. Lin, Y. S., and M. R. Green. 1989. Similarities between prokaryotic and eukaryotic cyclic AMP-responsive promoter elements. Nature 340:656-659.
35. Luo, Y., H. Yu, and B. M. Peterlin. 1994. Cellular protein modulates effects of human immunodeficiency virus type 1 Rev. J. Virol. 68:3850-3856.
36. Marriott, S. J., P. F. Lindholm, K. M. Brown, S. D. Gitlin, J. F. Duvall, M. F. Radonovich, and J. N. Brady. 1990. A 36-kilodalton cellular transcription factor mediates an indirect interaction of human T-cell leukemia/lymphoma virus type I TAXI with a responsive element in the viral long terminal repeat. Mol. Cell. Biol. 10:4192-4201.
37. McDonald, D., T. J. Hope, and T. G. Parslow. 1992. Postranscriptional regulation by the human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex proteins through a heterologous RNA binding site. J. Virol. 66:7232-7238.
38. Murphy, E. L., B. Hanchard, J. P. Figueroa, W. N. Gibbs, W. S. Lofters, M. Campbell, J. J. Goedert, and W. A. Blattner. 1989. Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int. J. Cancer 43:250-253.
39. Osame, M., K. Usuku, S. Izumo, N. Ijichi, H. Amitani, A. Igata, M. Matsumoto, and M. Tara. 1986. HTLV-I associated myelopathy, a new clinical entity [letter]. Lancet 1:1031-1032.
40. Osborne, S. E. Unpublished results.
41. Puglisi, J. D., L. Chen, S. Blanchard, and A. D. Frankel. 1995. Solution structure of a bovine immunodeficiency virus Tat-TAR peptide-RNA complex. Science 270:1200-1203.
42. Puglisi, J. D., R. Tan, B. J. Calnan, A. D. Frankel, and J. R. Williamson. 1992. Conformation of the TAR RNA-arginine complex by NMR spectroscopy. Science 257:76-80.
43. Rimsky, L., M. D. Dodon, E. P. Dixon, and W. C. Greene. 1989. Trans-dominant inactivation of HTLV-I and HIV-1 gene expression by mutation of the HTLV-I Rex transactivator. Nature 341:453-456.
44. Rimsky, L., J. Hauber, M. Dukovich, M. H. Malim, A. Langlois, B. R. Cullen, and W. C. Greene. 1988. Functional replacement of the HIV-1 rev protein by the HTLV-1 rex protein. Nature 335:738-740.
45. Seiki, M., J. Inoue, M. Hidaka, and M. Yoshida. 1988. Two cis-acting elements responsible for posttranscriptional trans-regulation of gene expression of human T-cell leukemia virus type I. Proc. Natl. Acad. Sci. USA 85:7124-7128.
46. Stutz, F., M. Neville, and M. Rosbash. 1995. Identification of a novel nuclear pore-associated protein as a functional target of the HIV-1 Rev protein in yeast. Cell 82:495-506.
47. Sullenger, B. A., H. F. Gallardo, G. E. Ungers, and E. Gilboa. 1990. Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication. Cell 63:601-608.
48. Symensma, T. L., L. Giver, M. Zapp, G. B. Takle, and A. D. Ellington. 1996. RNA aptamers selected to bind human immunodeficiency virus type 1 Rev in vitro are Rev responsive in vivo. J. Virol. 70:179-187.
49. Tan, R., L. Chen, J. A. Buettner, D. Hudson, and A. D. Frankel. 1993. RNA recognition by an isolated alpha helix. Cell 73:1031-1040.
50. Tao, J., and A. D. Frankel. 1996. Arginine-binding RNAs resembling TAR identified by in vitro selection. Biochemistry 35:2229-2238.
51. Toyoshima, H., M. Itoh, J.-I. Inoue, M. Seiki, F. Takaku, and M. Yoshida. 1990. Secondary structure of the human T-cell leukemia virus type 1 rex-responsive element is essential for rex regulation of RNA processing and transport of unspliced RNAs. J. Virol. 64:2825-2832.
52. Tuerk, C., and L. Gold. 1990. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249:505-510.
53. Tuerk, C., S. MacDougal, and L. Gold. 1992. RNA pseudoknots that inhibit human immunodeficiency virus type 1 reverse transcriptase. Proc. Natl. Acad. Sci. USA 89:6988-6992.
54. Tuerk, C., and S. MacDougal-Waugh. 1993. In vitro evolution of functional nucleic acids: high-affinity RNA ligands of HIV-1 proteins. Gene 137:33-39.
55. Unge, T., L. Solomin, M. Mellini, D. Derse, B. K. Felber, and G. N. Pavlakis. 1991. The Rex regulatory protein of human T-cell lymphotropic virus type I binds specifically to its target site within the viral RNA. Proc. Natl. Acad. Sci. USA 88:7145-7149.
56. Weeks, K. M., and D. M. Crothers. 1991. RNA recognition by Tat-derived peptides: interaction in the major groove? Cell 66:577-588. (Erratum, 70: 1069, 1992.)
57. Weichselbraun, I., G. K. Farrington, J. R. Rusche, E. Bohnlein, and J. Hauber. 1992. Definition of the human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex protein activation domain by functional exchange. J. Virol. 66:2583-2587.
58. Xu, W., and A. D. Ellington. 1996. Anti-peptide aptamers recognize amino acid sequence and bind a protein epitope. Proc. Natl. Acad. Sci. USA 93:7475-7480.
59. Ye, X., A. Gorin, A. D. Ellington, and D. J. Patel. 1996. Deep penetration of an alpha-helix into a widened RNA major groove in the HIV-1 rev peptide-RNA aptamer complex. Nat. Struct. Biol. 3:1026-1033.
60. Ye, X., R. A. Kumar, and D. J. Patel. 1995. Molecular recognition in the bovine immunodeficiency virus Tat peptide-TAR RNA complex. Chem. Biol. 2:827-840.
61. Yoshida, M., I. Miyoshi, and Y. Hinuma. 1982. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc. Natl. Acad. Sci. USA 79:2031-2035.
62. Zhao, L. J., and C. Z. Giam. 1991. Interaction of the human T-cell lymphotrophic virus type I (HTLV-I) transcriptional activator Tax with cellular factors that bind specifically to the 21-base-pair repeats in the HTLV-I enhancer. Proc. Natl. Acad. Sci. USA 88:11445-11449.